Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial.
Konde MK, Baker DP, Traore FA, Sow MS, Camara A, Barry AA, Mara D, Barry A, Cone M, Kaba I, Richard AA, Beavogui AH, Günther S; European Mobile Laboratory Consortium; Pintilie M, Fish EN. Konde MK, et al. PLoS One. 2017 Feb 22;12(2):e0169255. doi: 10.1371/journal.pone.0169255. eCollection 2017. PLoS One. 2017. PMID: 28225767 Free PMC article.
Toward Health System Recovery in the Aftermath of Ebola Outbreak in Guinea: New Approaches for Improved Knowledge of Target Populations at the Community Level.
Konde MK, Kéita BM, Massandouno L, Diallo A, Diallo M, Toure MA, Amadaye A, Camara A, Fode C, Delamou A, Beavogui AH, Diallo N, Ablam A, Bah Sow O, Barry SP, Subissi L, Standley C. Konde MK, et al. J Prim Care Community Health. 2022 Jan-Dec;13:21501319221074470. doi: 10.1177/21501319221074470. J Prim Care Community Health. 2022. PMID: 35638733 Free PMC article.
Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis.
Mellors J, Tipton T, Fehling SK, Akoi Bore J, Koundouno FR, Hall Y, Hudson J, Alexander F, Longet S, Taylor S, Gorringe A, Magassouba N, Konde MK, Hiscox J, Strecker T, Carroll M. Mellors J, et al. Among authors: konde mk. Front Immunol. 2022 Apr 12;13:857481. doi: 10.3389/fimmu.2022.857481. eCollection 2022. Front Immunol. 2022. PMID: 35493467 Free PMC article.
Subsequent mortality in survivors of Ebola virus disease in Guinea: a nationwide retrospective cohort study.
Keita M, Diallo B, Mesfin S, Marega A, Nebie KY, Magassouba N, Barry A, Coulibaly S, Barry B, Baldé MO, Pallawo R, Sow S, Bah AO, Balde MS, Van Gucht S, Kondé MK, Diallo AB, Djingarey MH, Fall IS, Formenty P, Glynn JR, Subissi L. Keita M, et al. Among authors: konde mk. Lancet Infect Dis. 2019 Nov;19(11):1202-1208. doi: 10.1016/S1473-3099(19)30313-5. Epub 2019 Sep 4. Lancet Infect Dis. 2019. PMID: 31494017
Use of Viremia to Evaluate the Baseline Case Fatality Ratio of Ebola Virus Disease and Inform Treatment Studies: A Retrospective Cohort Study.
Faye O, Andronico A, Faye O, Salje H, Boëlle PY, Magassouba N, Bah EI, Koivogui L, Diallo B, Diallo AA, Keita S, Konde MK, Fowler R, Fall G, Cauchemez S, Sall AA. Faye O, et al. Among authors: konde mk. PLoS Med. 2015 Dec 1;12(12):e1001908. doi: 10.1371/journal.pmed.1001908. eCollection 2015 Dec. PLoS Med. 2015. PMID: 26625118 Free PMC article.
Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa.
Carroll MW, Matthews DA, Hiscox JA, Elmore MJ, Pollakis G, Rambaut A, Hewson R, García-Dorival I, Bore JA, Koundouno R, Abdellati S, Afrough B, Aiyepada J, Akhilomen P, Asogun D, Atkinson B, Badusche M, Bah A, Bate S, Baumann J, Becker D, Becker-Ziaja B, Bocquin A, Borremans B, Bosworth A, Boettcher JP, Cannas A, Carletti F, Castilletti C, Clark S, Colavita F, Diederich S, Donatus A, Duraffour S, Ehichioya D, Ellerbrok H, Fernandez-Garcia MD, Fizet A, Fleischmann E, Gryseels S, Hermelink A, Hinzmann J, Hopf-Guevara U, Ighodalo Y, Jameson L, Kelterbaum A, Kis Z, Kloth S, Kohl C, Korva M, Kraus A, Kuisma E, Kurth A, Liedigk B, Logue CH, Lüdtke A, Maes P, McCowen J, Mély S, Mertens M, Meschi S, Meyer B, Michel J, Molkenthin P, Muñoz-Fontela C, Muth D, Newman EN, Ngabo D, Oestereich L, Okosun J, Olokor T, Omiunu R, Omomoh E, Pallasch E, Pályi B, Portmann J, Pottage T, Pratt C, Priesnitz S, Quartu S, Rappe J, Repits J, Richter M, Rudolf M, Sachse A, Schmidt KM, Schudt G, Strecker T, Thom R, Thomas S, Tobin E, Tolley H, Trautner J, Vermoesen T, Vitoriano I, Wagner M, Wolff S, Yue C, Capobianchi MR, Kretschmer B, Hall Y, Kenny JG, Rickett NY, Dudas G, Coltart CE, Kerber R, Steer D, Wrigh… See abstract for full author list ➔ Carroll MW, et al. Among authors: konde mk. Nature. 2015 Aug 6;524(7563):97-101. doi: 10.1038/nature14594. Epub 2015 Jun 17. Nature. 2015. PMID: 26083749 Free PMC article.
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).
Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell PS, Hossmann S, Watle SV, Kondé MK, Kéïta S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Røttingen JA, Kieny MP. Henao-Restrepo AM, et al. Among authors: konde mk. Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23. Lancet. 2017. PMID: 28017403 Free PMC article. Clinical Trial.
33 results